The Essential Guide to Pharmaceutical Market Access

Market access decides whether a breakthrough medicine actually reaches patients — and the people who control it are among the most in-demand hires in pharma and biotech.

This course is a complete, practical guide to pharmaceutical market access, taught by a market access professional with a master's in drug development who works inside a large pharmaceutical company. No theory-only lectures: every concept is tied to how launches, pricing decisions, and reimbursement negotiations really work.

WHAT YOU WILL MASTER

• Market access strategy — building access plans for new drug launches, from early pipeline to post-launch

• Health Technology Assessment (HTA) — how HTA bodies in the US, Canada, and Europe evaluate drugs, and what a winning submission looks like

• Pricing & reimbursement — the models and negotiations that decide what a drug costs and who pays

• Pharmacoeconomics & HEOR — cost-effectiveness (CEA), cost-utility (CUA), budget impact analysis (BIA), indirect treatment comparisons (ITC/MAIC)

• Real-world evidence (RWE) — collecting and using real-world data to support access and publications

• Stakeholder engagement & advocacy — working with payers, clinicians, regulators, and patient groups

• Careers — what market access managers actually do day to day, in both public and private payer systems

WHAT'S INCLUDED

• 4.5 hours of video lessons with clear explanations and real examples

• In-depth readings, study guides, and case studies (including a patient-centricity case study in myeloma)

• 48 downloadable resources — lecture notes, templates, and reference documents

• Section quizzes and a final exam to lock in your knowledge

• A hands-on assignment: build your own market access plan outline for a new launch

• Certificate of completion for your resume and LinkedIn

WHO THIS COURSE IS FOR

Aspiring market access and HEOR professionals, pharma and biotech staff who want the payer perspective, life-science students targeting industry roles, and consultants supporting launch strategy. No prior market access experience required.

By the end, you'll understand how access decisions are made, speak the language of payers and HTA bodies, and have a portfolio-ready plan that shows employers you can do the work.

Enroll now and start building your market access expertise.

COURSE UPDATE — OCTOBER 2026: This course has been expanded with two new sections — Access for Advanced Therapies (cell, gene and orphan drugs) and Innovative Pricing and Access Agreements — plus new video lessons throughout, including QALYs explained, a beginner's guide to real-world evidence, AI in market access, US vs Germany pricing compared, and Inside the Job: what market access roles actually require. Five quizzes and a launch-plan assignment are now included.